Skip to content

Benzamycin

Drug profile

Also known as: Benzoyl peroxide-erythromyxin mixt.

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Benzamycin is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including KCNH2, MLNR and CYP1B1. Recorded indications include Acne vulgaris.

  • Molecular targets: KCNH2, MLNR, CYP1B1 and AOX1 (4 listed in DrugCentral).
  • Indications: Acne vulgaris.
  • Molecular formula: C51H77NO17; molecular weight 976.17 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Acne vulgaris

Contraindications (2)

  • Erythroderma
  • Inflammatory dermatosis

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Potassium voltage-gated channel subfamily H member 2KCNH2unknownIC50 7.41
Motilin receptorMLNRunknownIC50 7.36
Cytochrome P450 1B1CYP1B1unknownIC50 4.40
Aldehyde oxidaseAOX1unknownIC50 4.01

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Benzamycin is on its molecule page.

Molecular formulaC51H77NO17
Molecular weight976.17 g/mol
CAS number376597-09-0
InChIKey—
PubChem CID12560

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Benzamycin used for?

DrugCentral lists the following indications for Benzamycin: Acne vulgaris.

How does Benzamycin work?

Its molecular targets in DrugCentral include KCNH2, MLNR, CYP1B1 and AOX1.

What is the chemical formula of Benzamycin?

Benzamycin has the molecular formula C51H77NO17 and a molecular weight of 976.17 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets4
Indications1
FormulaC51H77NO17
DrugCentral ID3875
Interactive profile